Craig Johnston is Industry Director at (CMAC) Continuous Manufacturing and Advanced Crystallisation. Established in 2011, CMAC is a world-class international centre for manufacturing research and training. Its vision is to lead the world in crystallisation and the adoption of continuous manufacturing. Working in partnership with industry it is transforming medicines manufacture. Craig works with Tier 1 industry members (GSK, AZ, Novartis, Bayer, Pfizer, Takeda, Eli Lilly, Roche and Pfizer) and a range of technology companies. Craig is a Fellow of the Institute of Chemical Engineers and has a MBA. His previous industrial career spanned 22 years, working for ICI, Zeneca, Avecia and Fujifilm. Responsibilities included plant management, new product introduction, process improvement, capital expenditure and process technology leadership. He was a Board Director with Britest. He is co-founder of sustainable protein business 3f Bio Ltd.